Logo image of FDMT

4D MOLECULAR THERAPEUTICS IN (FDMT) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:FDMT - US35104E1001 - Common Stock

7.68 USD
-0.29 (-3.64%)
Last: 12/29/2025, 8:00:02 PM
7.68 USD
0 (0%)
After Hours: 12/29/2025, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
FDMT revenue by date.FDMT revenue by date.
3.13M
-82.65%
20.723M
562.08%
37K
-99.82%
7.874M
21,181.08%
20.664M
162.43%
21.755M
5.28%
35.241M
61.99%
106.35M
201.78%
258.22M
142.80%
497.09M
92.51%
790.26M
58.98%
EBITDA
YoY % growth
FDMT ebitda by date.FDMT ebitda by date.
-107.63M
-54.18%
-108.663M
-0.96%
-183.188M
-68.58%
-213.305M
-16.44%
-244.946M
-14.83%
-275.877M
-12.63%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
FDMT ebit by date.FDMT ebit by date.
-110.03M
-54.25%
-112.867M
-2.58%
-187.841M
-66.43%
-215.646M
-14.80%
-247.639M
-14.84%
-278.866M
-12.61%
-371.2M
-33.11%
-389.536M
-4.94%
-291.014M
25.29%
-119.296M
59.01%
115.34M
196.68%
Operating Margin
FDMT operating margin by date.FDMT operating margin by date.
-3,515.34%-544.65%-507,678.38%-2,738.71%-1,198.41%-1,281.85%-1,053.32%-366.28%-112.70%-24.00%14.60%
EPS
YoY % growth
FDMT eps by date.FDMT eps by date.
-3.32
-29.69%
-2.64
20.48%
-2.98
-12.88%
-3.75
-25.86%
-3.55
5.39%
-3.52
0.90%
-3.98
-13.13%
-4.15
-4.27%
-2.86
31.07%
-0.68
76.22%
1.89
377.49%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.78
13.58%
-0.95
-10.70%
-0.89
9.10%
-0.92
8.77%
-0.85
-9.51%
Revenue
Q2Q % growth
9.364M
936,300.00%
8.16M
58,185.71%
8.16M
54,300.00%
8.16M
8,966.67%
8.16M
-12.86%
EBITDA
Q2Q % growth
-61.81M
-20.10%
-57.369M
-9.13%
-60.327M
-5.39%
-64.808M
-12.30%
N/A
EBIT
Q2Q % growth
-58.609M
-4.44%
-62.209M
-16.02%
-64.068M
-7.76%
-66.695M
-9.01%
-67.762M
-15.62%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.01
-27.85%
-1.00-0.01-1.18%
Q2 2025
Q2Q % growth
-0.98
-55.56%
-0.89-0.09-9.71%
Q1 2025
Q2Q % growth
-0.86
-30.30%
-0.880.022.21%
Q4 2024
Q2Q % growth
-0.90
-20.00%
-0.83-0.07-7.88%
Q3 2024
Q2Q % growth
-0.79
-229.17%
-0.72-0.07-10.47%
Q2 2024
Q2Q % growth
-0.63
18.18%
-0.720.0912.21%
Q1 2024
Q2Q % growth
-0.66
25.00%
-0.760.1013.06%
Q4 2023
Q2Q % growth
-0.75
10.71%
-0.760.010.80%
Q3 2023
Q2Q % growth
-0.24
69.62%
-0.610.3760.37%
Q2 2023
Q2Q % growth
-0.77
11.49%
-0.820.056.57%
Q1 2023
Q2Q % growth
-0.88
-7.32%
-0.910.033.50%
Q4 2022
Q2Q % growth
-0.84
1.18%
-0.80-0.04-4.77%
Q3 2022
Q2Q % growth
-0.79
3.66%
-0.930.1415.12%
Q2 2022
Q2Q % growth
-0.87
-210.71%
-0.870.00-0.35%
Q1 2022
Q2Q % growth
-0.82
-34.43%
-0.830.010.75%
Q4 2021
Q2Q % growth
-0.85
63.98%
-0.880.033.10%
Q3 2021
Q2Q % growth
-0.82 -0.820.000.13%
Q2 2021
Q2Q % growth
-0.28 -0.690.4159.63%
Q1 2021
Q2Q % growth
-0.61 -1.120.5145.63%
Q4 2020
Q2Q % growth
-2.36 -0.67-1.69-250.56%
FDMT Yearly EPS VS EstimatesFDMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
90K
2,900.00%
293.617K-203.617K-69.35%
Q2 2025
Q2Q % growth
15K
200.00%
381.623K-366.623K-96.07%
Q1 2025
Q2Q % growth
14K
-50.00%
390.221K-376.221K-96.41%
Q4 2024
Q2Q % growth
1K
-100.00%
1.747M-1.746M-99.94%
Q3 2024
Q2Q % growth
3K
-99.99%
569.456K-566.456K-99.47%
Q2 2024
Q2Q % growth
5K
-97.91%
1.337M-1.332M-99.63%
Q1 2024
Q2Q % growth
28K
-90.60%
800.7K-772.7K-96.50%
Q4 2023
Q2Q % growth
20.723M
1,557.84%
2.104M18.619M884.93%
Q3 2023
Q2Q % growth
20.204M
3,940.80%
8.19M12.014M146.69%
Q2 2023
Q2Q % growth
239K
49.38%
865.297K-626.297K-72.38%
Q1 2023
Q2Q % growth
298K
-75.57%
1.049M-751K-71.59%
Q4 2022
Q2Q % growth
1.25M
1,288.89%
3.066M-1.816M-59.23%
Q3 2022
Q2Q % growth
500K
-63.50%
893.775K-393.775K-44.06%
Q2 2022
Q2Q % growth
160K
-98.90%
873.12K-713.12K-81.67%
Q1 2022
Q2Q % growth
1.22M
-39.00%
775.2K444.8K57.38%
Q4 2021
Q2Q % growth
90K
109.18%
918K-828K-90.20%
Q3 2021
Q2Q % growth
1.37M
-90.61%
178.5K1.192M667.51%
Q2 2021
Q2Q % growth
14.58M 601.8K13.978M2,322.73%
Q4 2020
Q2Q % growth
-980K
-148.28%
%
Q3 2020
Q2Q % growth
14.589M
2,601.67%
%
FDMT Yearly Revenue VS EstimatesFDMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 14.46% 0.46% 0.46%
Revenue0% 183.41% 145.37% 145.37%